Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Infectious Disorders Drug Targets|July 25, 2018
Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, IranMehrnaz Rasoolinejad, Ehsan Najafi, Azar Hadadi, et al.Plos One|May 7, 2026
Integration of HIV, Hepatitis B, and C, and sexually transmitted infections services: A scoping review of the benefits and challengesParya Jangipour Afshar, Vahid Yazdi-Feyzabadi, Zahra Abdolahinia, et al.AIDS Care|June 28, 2021
Cascade of care in people living with HIV in Iran in 2019; how far to reach UNAIDS/WHO targetsBehnam Farhoudi, Nima Ghalekhani, Parvin Afsar Kazerooni, et al.Microbial Pathogenesis|May 4, 2020
HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platformMohammad Gholami, NeginHosseini Rouzbahani, SiamakMirab Samiee, et al.Intervirology|March 13, 2019
Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9-15 Months in 14 Triangular Clinics in Iran, 2015-2016Minoo Mohraz, Katayoun Tayeri, Hengameh Namdari Tabar, et al.International Immunopharmacology|May 20, 2021
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient settingMajid Mokhtari, Minoo Mohraz, Mohammad Mehdi Gouya, et al.Medical Journal of the Islamic Republic of Iran|July 19, 2021
Nationwide population-based surveys of Iranian COVID-19 Serological Surveillance (ICS) program: The surveys protocolKazem Khalagi, Safoora Gharibzadeh, Davood Khalili, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programmeKazem Khalagi, Safoora Gharibzadeh, Davood Khalili, et al.International Journal of Clinical Practice|April 30, 2021
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virusSeyed Ali Dehghan Manshadi, Shahin Merat, Minoo Mohraz, et al.Journal of Medical Virology|February 23, 2023
Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A national cohort study in IranHamidreza Jamaati, Saeed Karimi, Fariba Ghorbani, et al.Pageof 3